Human antibodies activate complement against Plasmodium falciparum sporozoites, and are associated with protection against malaria in children

Grants

Funding Acknowledgements

Funding was provided by PATH's Malaria Vaccine Initiative; the National Health and Medical Research Council (NHMRC) of Australia (program grant to JGB; research fellowships to JGB and IM); the National Institutes of Health; the Australian government's Research Training Program Scholarship; and the Nijmegen Institute for Infection, Inflammation and Immunity (N4i) for a PhD scholarship. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Burnet Institute is supported by an operational infrastructure support grant from Victoria's state government, and the infrastructure support scheme of the NHMRC Independent Research Institutes. This paper is published with permission from the director of the Kenya Medical Research Institute.